Tony Webster
A joint press release states that Kimberly-Clark will compensate Kenvue shareholders with $3.50 in cash and around 0.15 of its own shares for each share. The proposal prices Kenvue shares at $21.01, roughly 1.5 times the closing price from last Friday.
Shareholders of Kimberly-Clark will possess roughly 54% of the merged entity, while Kenvue shareholders will hold the rest. Together, the two firms generate about $32 billion in annual revenue.
Kenvue was separated from Johnson & Johnson in 2022. Kenvue offers products such as Neutrogena lotions, Band-Aid adhesive strips, Listerine oral rinse, Tylenol, a paracetamol equivalent, and the Johnson's Baby collection designed for kids.
source: reuters.com
Shareholders of Kimberly-Clark will possess roughly 54% of the merged entity, while Kenvue shareholders will hold the rest. Together, the two firms generate about $32 billion in annual revenue.
Kenvue was separated from Johnson & Johnson in 2022. Kenvue offers products such as Neutrogena lotions, Band-Aid adhesive strips, Listerine oral rinse, Tylenol, a paracetamol equivalent, and the Johnson's Baby collection designed for kids.
source: reuters.com